We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $10.9B
1-Year Est. Return 70.31%
This Fund
S&P 500
This Quarter Est. Return
+19.17%
1 Year Est. Return
+70.31%
3 Year Est. Return
+250.68%
5 Year Est. Return
+304.91%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.46B
Cap. Flow
+$1.48B
Cap. Flow %
13.59%
Top 10 Hldgs %
46.43%
Holding
101
New
18
Increased
33
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
FLR icon
Fluor
FLR
+$246M
2
AMZN icon
Amazon
AMZN
+$226M
3
GIL icon
Gildan
GIL
+$178M
4
ZM icon
Zoom
ZM
+$167M
5
PFSI icon
PennyMac Financial
PFSI
+$143M

Top Sells

Rank Stock Value
1
CEG icon
Constellation Energy
CEG
+$200M
2
AKAM icon
Akamai
AKAM
+$149M
3
TDS icon
Telephone and Data Systems
TDS
+$77.9M
4
ADEA icon
Adeia
ADEA
+$63.7M
5
MCY icon
Mercury Insurance
MCY
+$60.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.1%
2 Utilities 18.51%
3 Industrials 14.52%
4 Consumer Discretionary 7.69%
5 Energy 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLN
1
Talen Energy Corp
TLN
$14.2B
$1.38B 12.7%
3,602,171
– –
FTAI icon
2
FTAI Aviation
FTAI
$20B
$812M 7.45%
3,000,000
+423,814
+16% +$107M
VTRS icon
3
Viatris
VTRS
$18.8B
$543M 4.98%
34,168,743
+668,743
+2% +$10.4M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$42.5B
$528M 4.84%
15,575,000
+325,000
+2% +$10.8M
GLNG icon
5
Golar LNG
GLNG
$5.13B
$457M 4.2%
9,178,978
– –
VST icon
6
Vistra
VST
$46B
$285M 2.61%
1,794,953
+294,953
+20% +$45.8M
TAC icon
7
TransAlta
TAC
$3.86B
$280M 2.57%
20,232,011
+2,450,686
+14% +$32.4M
FLR icon
8
Fluor
FLR
$7.12B
$263M 2.41%
+5,017,248
New +$246M
KNSA icon
9
Kiniksa Pharmaceuticals
KNSA
$6.09B
$256M 2.35%
3,999,800
+249,800
+7% +$13M
BGC icon
10
BGC Group
BGC
$5.76B
$254M 2.33%
23,800,000
+500,000
+2% +$5.59M
ZM icon
11
Zoom
ZM
$28.7B
$239M 2.19%
2,766,009
+1,765,003
+176% +$167M
GIL icon
12
Gildan
GIL
$9.84B
$232M 2.13%
4,500,000
+3,104,210
+222% +$178M
ARQT icon
13
Arcutis Biotherapeutics
ARQT
$2.99B
$217M 1.99%
8,271,577
– –
AMZN icon
14
Amazon
AMZN
$2.87T
$215M 1.97%
+900,000
New +$226M
ROIV icon
15
Roivant Sciences
ROIV
$25.1B
$212M 1.95%
6,000,000
+1,000,000
+20% +$29.6M
ZYME icon
16
Zymeworks
ZYME
$2.02B
$183M 1.68%
7,000,000
– –
AMCR icon
17
Amcor
AMCR
$21.6B
$180M 1.66%
4,162,030
+2,892,634
+228% +$115M
CMPR icon
18
Cimpress
CMPR
$2.17B
$178M 1.63%
1,750,000
+120,581
+7% +$10.7M
AMRX icon
19
Amneal Pharmaceuticals
AMRX
$6.11B
$176M 1.61%
10,168,660
-868,929
-8% -$11.9M
NRIX icon
20
Nurix Therapeutics
NRIX
$2.72B
$175M 1.61%
7,227,778
+4,753,893
+192% +$81M
MCY icon
21
Mercury Insurance
MCY
$5.7B
$164M 1.51%
1,541,440
-613,064
-28% -$60.4M
PFSI icon
22
PennyMac Financial
PFSI
$3.81B
$148M 1.36%
1,700,000
+1,645,273
+3,006% +$143M
IART icon
23
Integra LifeSciences
IART
$1.31B
$139M 1.28%
7,753,934
– –
DK icon
24
Delek US
DK
$4.42B
$137M 1.25%
2,687,449
– –
LBTYA icon
25
Liberty Global Class A
LBTYA
$3.64B
$134M 1.23%
11,752,855
– –
1
2 3 4

Similar funds

MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.9B AUM 37.22% 1-Year Est. Return
LCAM
London & Capital Asset Management London, United Kingdom $10.9B AUM 39.88% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
RCMF
RK Capital Management (Florida) Weston, Florida $10.8B AUM 53.02% 1-Year Est. Return
SIM
SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Rubric Capital Management (New York)'s Q2 2026 Portfolio in Review

As of Q2 2026, Rubric Capital Management (New York) held 101 positions worth $10.9B, up 15% from $9.44B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Rubric Capital Management (New York) deployed $1.48B of net new capital in Q2 2026, opening 18 new positions and adding to 33 existing holdings. Its largest new stake was Fluor: 5,017,248 shares worth $263M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 28% a quarter earlier, followed by Utilities and Industrials.

On the sell side, the largest reduction was Adeia, an estimated $63.7M trimmed.

  • Rubric Capital Management (New York)'s largest Q2 2026 buy was Fluor: 5,017,248 shares worth $263M.
  • Rubric Capital Management (New York) added most to Gildan in Q2 2026, an estimated $178M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2026 reduction was Adeia, cutting an estimated $63.7M.
  • Rubric Capital Management (New York) fully exited Constellation Energy in Q2 2026, selling an estimated $200M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 46% of its $10.9B portfolio in Q2 2026.
  • Rubric Capital Management (New York) opened 18 new positions and closed 14 in Q2 2026.
  • Rubric Capital Management (New York)'s portfolio value rose 15% quarter-over-quarter to $10.9B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.